Cargando…

Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.

Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pukhalsky, A L, Kapranov, N I, Kalashnikova, E A, Shmarina, G V, Shabalova, L A, Kokarovtseva, S N, Pukhalskaya, D A, Kashirskaja, N J, Simonova, O I
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781793/
https://www.ncbi.nlm.nih.gov/pubmed/10704054
_version_ 1782131973015207936
author Pukhalsky, A L
Kapranov, N I
Kalashnikova, E A
Shmarina, G V
Shabalova, L A
Kokarovtseva, S N
Pukhalskaya, D A
Kashirskaja, N J
Simonova, O I
author_facet Pukhalsky, A L
Kapranov, N I
Kalashnikova, E A
Shmarina, G V
Shabalova, L A
Kokarovtseva, S N
Pukhalskaya, D A
Kashirskaja, N J
Simonova, O I
author_sort Pukhalsky, A L
collection PubMed
description Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy.
format Text
id pubmed-1781793
institution National Center for Biotechnology Information
language English
publishDate 1999
record_format MEDLINE/PubMed
spelling pubmed-17817932007-01-25 Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. Pukhalsky, A L Kapranov, N I Kalashnikova, E A Shmarina, G V Shabalova, L A Kokarovtseva, S N Pukhalskaya, D A Kashirskaja, N J Simonova, O I Mediators Inflamm Research Article Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy. 1999 /pmc/articles/PMC1781793/ /pubmed/10704054 Text en
spellingShingle Research Article
Pukhalsky, A L
Kapranov, N I
Kalashnikova, E A
Shmarina, G V
Shabalova, L A
Kokarovtseva, S N
Pukhalskaya, D A
Kashirskaja, N J
Simonova, O I
Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title_full Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title_fullStr Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title_full_unstemmed Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title_short Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
title_sort inflammatory markers in cystic fibrosis patients with lung pseudomonas aeruginosa infection.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781793/
https://www.ncbi.nlm.nih.gov/pubmed/10704054
work_keys_str_mv AT pukhalskyal inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT kapranovni inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT kalashnikovaea inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT shmarinagv inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT shabalovala inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT kokarovtsevasn inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT pukhalskayada inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT kashirskajanj inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection
AT simonovaoi inflammatorymarkersincysticfibrosispatientswithlungpseudomonasaeruginosainfection